<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The role of the renin-angiotensin system in <z:hpo ids='HP_0100543'>cognitive impairment</z:hpo> is unclear </plain></SENT>
<SENT sid="1" pm="."><plain>This work was undertaken to test our hypothesis that renin-angiotensin system may contribute to <z:hpo ids='HP_0001268'>cognitive decline</z:hpo> and brain damage caused by <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>C57BL/6J mice were subjected to bilateral common carotid <z:mp ids='MP_0006135'>artery stenosis</z:mp> with microcoil to prepare mice with <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:e sem="disease" ids="C1695782" disease_type="Disease or Syndrome" abbrv="">cerebral hypoperfusion</z:e>, a model of subcortical vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>The effects of <z:chebi fb="0" ids="601027">aliskiren</z:chebi>, a direct renin inhibitor, or Tempol, a <z:chebi fb="1" ids="18421">superoxide</z:chebi> scavenger, on brain damage and working memory in these mice were examined </plain></SENT>
<SENT sid="4" pm="."><plain><z:hpo ids='HP_0011010'>Chronic</z:hpo> <z:e sem="disease" ids="C1695782" disease_type="Disease or Syndrome" abbrv="">cerebral hypoperfusion</z:e> significantly increased brain renin activity and angiotensinogen expression in C57BL/6J mice, which was attributed to the increased renin in activated astrocytes and microvessels and the increased angiotensinogen in activated astrocytes in white matter </plain></SENT>
<SENT sid="5" pm="."><plain><z:chebi fb="0" ids="601027">Aliskiren</z:chebi> pretreatment significantly inhibited brain renin activity and ameliorated brain p67(phox)-related <z:chebi fb="1" ids="16474">NADPH</z:chebi> oxidase activity, <z:mp ids='MP_0003674'>oxidative stress</z:mp>, glial activation, white matter lesion, and spatial working <z:e sem="disease" ids="C0233794" disease_type="Mental or Behavioral Dysfunction" abbrv="">memory deficits</z:e> in C57BL/6J mice with bilateral common carotid <z:mp ids='MP_0006135'>artery stenosis</z:mp> </plain></SENT>
<SENT sid="6" pm="."><plain>To elucidate the role of <z:mp ids='MP_0003674'>oxidative stress</z:mp> in brain protective effects of <z:chebi fb="0" ids="601027">aliskiren</z:chebi>, we also examined the effect of Tempol in the same mice with bilateral common carotid <z:mp ids='MP_0006135'>artery stenosis</z:mp> </plain></SENT>
<SENT sid="7" pm="."><plain>Tempol pretreatment mimicked the brain protective effects of <z:chebi fb="0" ids="601027">aliskiren</z:chebi> in this mouse model </plain></SENT>
<SENT sid="8" pm="."><plain>Posttreatment of mice with <z:chebi fb="0" ids="601027">aliskiren</z:chebi> or Tempol after bilateral common carotid <z:mp ids='MP_0006135'>artery stenosis</z:mp> also prevented <z:hpo ids='HP_0001268'>cognitive decline</z:hpo> </plain></SENT>
<SENT sid="9" pm="."><plain>In conclusion, <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:e sem="disease" ids="C1695782" disease_type="Disease or Syndrome" abbrv="">cerebral hypoperfusion</z:e> induced the activation of the brain renin-angiotensin system </plain></SENT>
<SENT sid="10" pm="."><plain><z:chebi fb="0" ids="601027">Aliskiren</z:chebi> ameliorated brain damage and working <z:e sem="disease" ids="C0233794" disease_type="Mental or Behavioral Dysfunction" abbrv="">memory deficits</z:e> in the model of <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> through the attenuation of <z:mp ids='MP_0003674'>oxidative stress</z:mp> </plain></SENT>
<SENT sid="11" pm="."><plain>Thus, direct renin inhibition seems to be a promising therapeutic strategy for subcortical vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> </plain></SENT>
</text></document>